| 0 |
APPENDICOLITH |
220 |
0.5685 |
| 1 |
SLEEP DISORDER THERAPY |
72 |
0.3636 |
| 2 |
ANTACID THERAPY |
44 |
0.3385 |
| 3 |
ELECTROCARDIOGRAM T WAVE ALTERNANS |
12 |
0.2791 |
| 4 |
VITAMIN B1 INCREASED |
13 |
0.2766 |
| 5 |
ANALGESIC THERAPY |
70 |
0.2181 |
| 6 |
DIABETIC MACROANGIOPATHY |
7 |
0.2121 |
| 7 |
SCHIZENCEPHALY |
9 |
0.2000 |
| 8 |
DRUG THERAPY |
66 |
0.1947 |
| 9 |
BLOOD LACTIC ACID DECREASED |
30 |
0.1744 |
| 10 |
CARDIAC OUTPUT INCREASED |
28 |
0.1637 |
| 11 |
COVID-19 TREATMENT |
11 |
0.1618 |
| 12 |
CEREBRAL HAEMORRHAGE FOETAL |
9 |
0.1475 |
| 13 |
ANTICOAGULANT THERAPY |
41 |
0.1444 |
| 14 |
SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE |
12 |
0.1429 |
| 15 |
MYOGLOBIN URINE PRESENT |
35 |
0.1423 |
| 16 |
VITAMIN B1 DECREASED |
32 |
0.1275 |
| 17 |
BACTEROIDES INFECTION |
30 |
0.1149 |
| 18 |
CONGENITAL HIATUS HERNIA |
25 |
0.1096 |
| 19 |
SIGMOID SINUS THROMBOSIS |
7 |
0.1061 |
| 20 |
MALIGNANT MELANOMA STAGE 0 |
22 |
0.1053 |
| 21 |
PROPOFOL INFUSION SYNDROME |
74 |
0.1050 |
| 22 |
MYOCARDIAL CALCIFICATION |
12 |
0.1026 |
| 23 |
ELECTROCARDIOGRAM U WAVE PRESENT |
6 |
0.0968 |
| 24 |
BURKHOLDERIA TEST POSITIVE |
12 |
0.0968 |
| 25 |
LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION |
29 |
0.0833 |
| 26 |
ADRENERGIC SYNDROME |
6 |
0.0741 |
| 27 |
VASOPLEGIA SYNDROME |
118 |
0.0719 |
| 28 |
HYPERDYNAMIC LEFT VENTRICLE |
16 |
0.0650 |
| 29 |
CAFE AU LAIT SPOTS |
6 |
0.0600 |
| 30 |
VASCULAR RESISTANCE SYSTEMIC DECREASED |
8 |
0.0597 |
| 31 |
DRY GANGRENE |
37 |
0.0583 |
| 32 |
BLOOD PHOSPHORUS INCREASED |
147 |
0.0538 |
| 33 |
PULMONARY HAEMATOMA |
6 |
0.0513 |
| 34 |
MYOGLOBINAEMIA |
6 |
0.0508 |
| 35 |
GENITAL EROSION |
14 |
0.0471 |
| 36 |
ANION GAP |
29 |
0.0457 |
| 37 |
HYPERPHOSPHATAEMIA |
98 |
0.0455 |
| 38 |
ACID BASE BALANCE ABNORMAL |
10 |
0.0446 |
| 39 |
PULMONARY HYPERTENSIVE CRISIS |
12 |
0.0443 |
| 40 |
PHAEOCHROMOCYTOMA CRISIS |
9 |
0.0425 |
| 41 |
CARDIOGENIC SHOCK |
535 |
0.0372 |
| 42 |
DISTRIBUTIVE SHOCK |
82 |
0.0362 |
| 43 |
HYPERLACTACIDAEMIA |
97 |
0.0361 |
| 44 |
RESPIRATORY GAS EXCHANGE DISORDER |
13 |
0.0350 |
| 45 |
ANTIBIOTIC LEVEL ABOVE THERAPEUTIC |
13 |
0.0320 |
| 46 |
MEAN ARTERIAL PRESSURE DECREASED |
8 |
0.0316 |
| 47 |
MYOCARDIAL DEPRESSION |
8 |
0.0310 |
| 48 |
SYSTOLIC DYSFUNCTION |
32 |
0.0304 |
| 49 |
RENAL CORTICAL NECROSIS |
7 |
0.0300 |
| 50 |
GASTROINTESTINAL ISCHAEMIA |
8 |
0.0289 |
| 51 |
HUMAN HERPESVIRUS 6 INFECTION REACTIVATION |
10 |
0.0285 |
| 52 |
PHARYNGEAL HAEMORRHAGE |
35 |
0.0284 |
| 53 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
26 |
0.0280 |
| 54 |
CUTANEOUS MUCORMYCOSIS |
5 |
0.0272 |
| 55 |
CYTOTOXIC OEDEMA |
7 |
0.0264 |
| 56 |
LOCKED-IN SYNDROME |
12 |
0.0260 |
| 57 |
NECROSIS ISCHAEMIC |
12 |
0.0260 |
| 58 |
HAEMODYNAMIC INSTABILITY |
195 |
0.0256 |
| 59 |
DISSEMINATED MUCORMYCOSIS |
10 |
0.0254 |
| 60 |
DIABETES INSIPIDUS |
61 |
0.0253 |
| 61 |
KIDNEY DUPLEX |
6 |
0.0250 |
| 62 |
ELECTROCARDIOGRAM P WAVE ABNORMAL |
6 |
0.0245 |
| 63 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
693 |
0.0244 |
| 64 |
APPENDICITIS |
225 |
0.0241 |
| 65 |
LARYNGOMALACIA |
8 |
0.0239 |
| 66 |
EXTREMITY NECROSIS |
41 |
0.0235 |
| 67 |
PNEUMONITIS ASPIRATION |
8 |
0.0234 |
| 68 |
VENTRICULAR FIBRILLATION |
256 |
0.0230 |
| 69 |
PERIPHERAL ISCHAEMIA |
94 |
0.0230 |
| 70 |
DISSEMINATED STRONGYLOIDIASIS |
5 |
0.0228 |
| 71 |
CSF PRESSURE INCREASED |
6 |
0.0226 |
| 72 |
PULSELESS ELECTRICAL ACTIVITY |
93 |
0.0222 |
| 73 |
FOETAL EXPOSURE DURING DELIVERY |
15 |
0.0221 |
| 74 |
TUBERCULOSIS GASTROINTESTINAL |
7 |
0.0219 |
| 75 |
TOTAL LUNG CAPACITY DECREASED |
34 |
0.0213 |
| 76 |
BRONCHOPULMONARY DYSPLASIA |
17 |
0.0211 |
| 77 |
METHAEMOGLOBINAEMIA |
48 |
0.0207 |
| 78 |
CLOSTRIDIAL SEPSIS |
5 |
0.0207 |
| 79 |
ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED |
7 |
0.0205 |
| 80 |
ISCHAEMIC HEPATITIS |
28 |
0.0204 |
| 81 |
MATERNAL EXPOSURE DURING DELIVERY |
20 |
0.0202 |
| 82 |
PNEUMONIA NECROTISING |
13 |
0.0201 |
| 83 |
VASOCONSTRICTION |
17 |
0.0194 |
| 84 |
STRESS CARDIOMYOPATHY |
113 |
0.0194 |
| 85 |
IRON DEFICIENCY |
84 |
0.0187 |
| 86 |
BLINDNESS CORTICAL |
9 |
0.0184 |
| 87 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
15 |
0.0182 |
| 88 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
93 |
0.0181 |
| 89 |
NECROTISING OESOPHAGITIS |
9 |
0.0180 |
| 90 |
BLOOD URIC ACID INCREASED |
104 |
0.0180 |
| 91 |
ACUTE LUNG INJURY |
21 |
0.0177 |
| 92 |
COMPARTMENT SYNDROME |
46 |
0.0176 |
| 93 |
SHOCK |
399 |
0.0173 |
| 94 |
ANION GAP INCREASED |
23 |
0.0172 |
| 95 |
DILATATION INTRAHEPATIC DUCT ACQUIRED |
5 |
0.0171 |
| 96 |
VENTRICULAR HYPOKINESIA |
55 |
0.0171 |
| 97 |
MYOCARDIAL INJURY |
19 |
0.0169 |
| 98 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
85 |
0.0168 |
| 99 |
DEVICE COMPUTER ISSUE |
5 |
0.0167 |
| 100 |
SYMPTOM MASKED |
12 |
0.0165 |
| 101 |
MUCOSAL EROSION |
15 |
0.0165 |
| 102 |
PROCEDURAL HYPOTENSION |
14 |
0.0165 |
| 103 |
ABDOMINAL COMPARTMENT SYNDROME |
10 |
0.0157 |
| 104 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
31 |
0.0157 |
| 105 |
HYPERTHERMIA MALIGNANT |
23 |
0.0154 |
| 106 |
ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY |
12 |
0.0154 |
| 107 |
LIMB AMPUTATION |
6 |
0.0151 |
| 108 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
16 |
0.0145 |
| 109 |
DRUG EFFECT PROLONGED |
8 |
0.0145 |
| 110 |
LUNG OPACITY |
38 |
0.0144 |
| 111 |
HYPOPHOSPHATAEMIA |
106 |
0.0143 |
| 112 |
BRASH SYNDROME |
20 |
0.0142 |
| 113 |
JARISCH-HERXHEIMER REACTION |
10 |
0.0140 |
| 114 |
MECHANICAL ILEUS |
8 |
0.0140 |
| 115 |
LABORATORY TEST INTERFERENCE |
11 |
0.0140 |
| 116 |
APALLIC SYNDROME |
10 |
0.0138 |
| 117 |
ACINETOBACTER INFECTION |
15 |
0.0137 |
| 118 |
LOWER RESPIRATORY TRACT INFECTION BACTERIAL |
7 |
0.0137 |
| 119 |
LEFT VENTRICULAR DILATATION |
7 |
0.0137 |
| 120 |
MYASTHENIA GRAVIS |
110 |
0.0136 |
| 121 |
AORTIC STENOSIS |
47 |
0.0135 |
| 122 |
RESPIRATORY TRACT HAEMORRHAGE |
8 |
0.0134 |
| 123 |
NEURODEVELOPMENTAL DISORDER |
9 |
0.0133 |
| 124 |
TROPONIN INCREASED |
101 |
0.0133 |
| 125 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
14 |
0.0132 |
| 126 |
ACIDOSIS |
100 |
0.0131 |
| 127 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
230 |
0.0130 |
| 128 |
EAR MALFORMATION |
6 |
0.0130 |
| 129 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
28 |
0.0127 |
| 130 |
WOLFF-PARKINSON-WHITE SYNDROME |
6 |
0.0127 |
| 131 |
NEONATAL ASPHYXIA |
9 |
0.0127 |
| 132 |
DELAYED GRAFT FUNCTION |
9 |
0.0127 |
| 133 |
APGAR SCORE LOW |
16 |
0.0124 |
| 134 |
NON-CARDIOGENIC PULMONARY OEDEMA |
13 |
0.0123 |
| 135 |
BRAIN DEATH |
38 |
0.0123 |
| 136 |
SUBCUTANEOUS EMPHYSEMA |
12 |
0.0122 |
| 137 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
60 |
0.0122 |
| 138 |
FUNGAL SEPSIS |
10 |
0.0120 |
| 139 |
INTESTINAL ISCHAEMIA |
65 |
0.0118 |
| 140 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
39 |
0.0118 |
| 141 |
RESPIRATORY ACIDOSIS |
46 |
0.0117 |
| 142 |
METABOLIC ACIDOSIS |
372 |
0.0116 |
| 143 |
RETINAL ISCHAEMIA |
7 |
0.0115 |
| 144 |
HYPOPERFUSION |
12 |
0.0114 |
| 145 |
ANAL STENOSIS |
6 |
0.0113 |
| 146 |
BLOOD MAGNESIUM INCREASED |
10 |
0.0111 |
| 147 |
SEPSIS NEONATAL |
9 |
0.0111 |
| 148 |
DYSBIOSIS |
9 |
0.0110 |
| 149 |
CLOSTRIDIUM TEST POSITIVE |
24 |
0.0109 |
| 150 |
SERRATIA INFECTION |
8 |
0.0107 |
| 151 |
SEPTIC SHOCK |
465 |
0.0107 |
| 152 |
TOXIC EPIDERMAL NECROLYSIS |
161 |
0.0106 |
| 153 |
NODAL ARRHYTHMIA |
9 |
0.0105 |
| 154 |
MOTOR DEVELOPMENTAL DELAY |
6 |
0.0104 |
| 155 |
CYTOKINE STORM |
7 |
0.0102 |
| 156 |
OLIGURIA |
63 |
0.0101 |
| 157 |
VENTRICULAR ARRHYTHMIA |
37 |
0.0101 |
| 158 |
LACTIC ACIDOSIS |
326 |
0.0101 |
| 159 |
COMA SCALE ABNORMAL |
29 |
0.0100 |
| 160 |
HYPERCAPNIA |
30 |
0.0100 |
| 161 |
PERFORATION |
8 |
0.0099 |
| 162 |
AMYLASE INCREASED |
36 |
0.0097 |
| 163 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
42 |
0.0097 |
| 164 |
NODAL RHYTHM |
14 |
0.0096 |
| 165 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
25 |
0.0095 |
| 166 |
PHIMOSIS |
7 |
0.0095 |
| 167 |
TOXIC ENCEPHALOPATHY |
48 |
0.0095 |
| 168 |
ANURIA |
80 |
0.0093 |
| 169 |
VENTRICULAR TACHYCARDIA |
153 |
0.0093 |
| 170 |
PULSE ABSENT |
44 |
0.0092 |
| 171 |
MUCORMYCOSIS |
24 |
0.0092 |
| 172 |
CARDIOVASCULAR INSUFFICIENCY |
15 |
0.0092 |
| 173 |
ISCHAEMIA |
42 |
0.0091 |
| 174 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
24 |
0.0090 |
| 175 |
CEREBELLAR INFARCTION |
15 |
0.0089 |
| 176 |
ASCITES |
260 |
0.0088 |
| 177 |
PATENT DUCTUS ARTERIOSUS |
35 |
0.0088 |
| 178 |
PUPIL FIXED |
15 |
0.0087 |
| 179 |
INFANTILE APNOEA |
7 |
0.0086 |
| 180 |
FANCONI SYNDROME |
12 |
0.0085 |
| 181 |
ARTERIOSPASM CORONARY |
34 |
0.0085 |
| 182 |
PNEUMATOSIS INTESTINALIS |
24 |
0.0084 |
| 183 |
FUNGAEMIA |
13 |
0.0083 |
| 184 |
CONTINUOUS HAEMODIAFILTRATION |
8 |
0.0082 |
| 185 |
ANTICHOLINERGIC SYNDROME |
13 |
0.0082 |
| 186 |
HEART SOUNDS ABNORMAL |
6 |
0.0080 |
| 187 |
BEZOAR |
11 |
0.0080 |
| 188 |
PLEURITIC PAIN |
22 |
0.0080 |
| 189 |
SEROTONIN SYNDROME |
153 |
0.0080 |
| 190 |
DILATED CARDIOMYOPATHY |
8 |
0.0079 |
| 191 |
GASTROINTESTINAL NECROSIS |
23 |
0.0079 |
| 192 |
ELECTROCARDIOGRAM PR PROLONGATION |
6 |
0.0078 |
| 193 |
KLEBSIELLA INFECTION |
39 |
0.0077 |
| 194 |
CRITICAL ILLNESS |
6 |
0.0077 |
| 195 |
CIRCULATORY COLLAPSE |
131 |
0.0077 |
| 196 |
COLOUR BLINDNESS |
7 |
0.0076 |
| 197 |
BLOOD FIBRINOGEN INCREASED |
6 |
0.0076 |
| 198 |
HAEMOTHORAX |
22 |
0.0076 |
| 199 |
PRODUCT CONTAMINATION MICROBIAL |
9 |
0.0075 |
| 200 |
PULMONARY VALVE STENOSIS |
6 |
0.0075 |
| 201 |
HAEMATOMA MUSCLE |
9 |
0.0075 |
| 202 |
HAEMOPERITONEUM |
6 |
0.0075 |
| 203 |
EMBOLISM ARTERIAL |
9 |
0.0075 |
| 204 |
HYPERVOLAEMIA |
37 |
0.0075 |
| 205 |
ACUTE LEFT VENTRICULAR FAILURE |
5 |
0.0074 |
| 206 |
PERICARDIAL HAEMORRHAGE |
16 |
0.0073 |
| 207 |
DISSEMINATED INTRAVASCULAR COAGULATION |
103 |
0.0073 |
| 208 |
BRADYCARDIA FOETAL |
6 |
0.0072 |
| 209 |
DEVELOPMENTAL HIP DYSPLASIA |
6 |
0.0072 |
| 210 |
RASH MORBILLIFORM |
20 |
0.0072 |
| 211 |
BLOOD LACTIC ACID INCREASED |
38 |
0.0072 |
| 212 |
MYOGLOBIN BLOOD INCREASED |
11 |
0.0072 |
| 213 |
RESPIRATORY DEPRESSION |
88 |
0.0072 |
| 214 |
KLEBSIELLA SEPSIS |
8 |
0.0071 |
| 215 |
BRADYPNOEA |
19 |
0.0070 |
| 216 |
RIGHT VENTRICULAR FAILURE |
49 |
0.0070 |
| 217 |
GANGRENE |
42 |
0.0070 |
| 218 |
NEPHROGENIC DIABETES INSIPIDUS |
8 |
0.0069 |
| 219 |
LOW BIRTH WEIGHT BABY |
55 |
0.0069 |
| 220 |
CARDIAC ARREST |
571 |
0.0069 |
| 221 |
TORSADE DE POINTES |
54 |
0.0069 |
| 222 |
METABOLIC ALKALOSIS |
11 |
0.0069 |
| 223 |
ANTIPHOSPHOLIPID SYNDROME |
11 |
0.0068 |
| 224 |
INTESTINAL PSEUDO-OBSTRUCTION |
6 |
0.0068 |
| 225 |
STRONGYLOIDIASIS |
11 |
0.0068 |
| 226 |
CARDIAC OUTPUT DECREASED |
6 |
0.0068 |
| 227 |
SYSTEMIC CANDIDA |
17 |
0.0068 |
| 228 |
LIVEDO RETICULARIS |
14 |
0.0067 |
| 229 |
CANDIDA SEPSIS |
6 |
0.0067 |
| 230 |
ESCHERICHIA TEST POSITIVE |
8 |
0.0067 |
| 231 |
WRONG PRODUCT ADMINISTERED |
45 |
0.0067 |
| 232 |
ENTEROCOCCAL BACTERAEMIA |
7 |
0.0066 |
| 233 |
MUSCLE NECROSIS |
6 |
0.0066 |
| 234 |
PNEUMOPERITONEUM |
12 |
0.0065 |
| 235 |
RENAL TUBULAR NECROSIS |
63 |
0.0064 |
| 236 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
110 |
0.0064 |
| 237 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
38 |
0.0064 |
| 238 |
MEGACOLON |
10 |
0.0064 |
| 239 |
BRAIN HERNIATION |
19 |
0.0064 |
| 240 |
RIGHT VENTRICULAR DYSFUNCTION |
7 |
0.0063 |
| 241 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
163 |
0.0063 |
| 242 |
BACTERIAL INFECTION |
117 |
0.0063 |
| 243 |
PYELOCALIECTASIS |
6 |
0.0063 |
| 244 |
COAGULOPATHY |
104 |
0.0062 |
| 245 |
PULMONARY SEPSIS |
9 |
0.0062 |
| 246 |
BRADYCARDIA |
326 |
0.0061 |
| 247 |
OPTIC NERVE INJURY |
7 |
0.0060 |
| 248 |
CATHETER SITE HAEMORRHAGE |
15 |
0.0060 |
| 249 |
PNEUMONIA KLEBSIELLA |
11 |
0.0060 |
| 250 |
PROCALCITONIN INCREASED |
7 |
0.0060 |
| 251 |
DEVICE RELATED SEPSIS |
12 |
0.0060 |
| 252 |
VASODILATATION |
15 |
0.0059 |
| 253 |
HYPOXIA |
208 |
0.0059 |
| 254 |
ACUTE RESPIRATORY FAILURE |
113 |
0.0059 |
| 255 |
ELECTROCARDIOGRAM QT PROLONGED |
211 |
0.0059 |
| 256 |
BLOOD PH DECREASED |
10 |
0.0058 |
| 257 |
LONG QT SYNDROME |
14 |
0.0058 |
| 258 |
CARDIOTOXICITY |
52 |
0.0058 |
| 259 |
BRUGADA SYNDROME |
6 |
0.0058 |
| 260 |
BILIARY TRACT DISORDER |
8 |
0.0058 |
| 261 |
KOUNIS SYNDROME |
13 |
0.0057 |
| 262 |
SINUS BRADYCARDIA |
55 |
0.0057 |
| 263 |
CEREBELLAR ATROPHY |
5 |
0.0057 |
| 264 |
FOETAL DISTRESS SYNDROME |
12 |
0.0057 |
| 265 |
SUPRAVENTRICULAR TACHYCARDIA |
54 |
0.0056 |
| 266 |
INTENTIONAL OVERDOSE |
360 |
0.0056 |
| 267 |
CEREBELLAR HAEMORRHAGE |
8 |
0.0056 |
| 268 |
PSEUDOMONAS INFECTION |
48 |
0.0056 |
| 269 |
MULTI-ORGAN DISORDER |
11 |
0.0056 |
| 270 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
43 |
0.0055 |
| 271 |
PNEUMOMEDIASTINUM |
10 |
0.0055 |
| 272 |
PREMATURE DELIVERY |
88 |
0.0055 |
| 273 |
LEFT VENTRICULAR DYSFUNCTION |
37 |
0.0055 |
| 274 |
ANGLE CLOSURE GLAUCOMA |
14 |
0.0055 |
| 275 |
HYPERNATRAEMIA |
27 |
0.0054 |
| 276 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
5 |
0.0054 |
| 277 |
TROPONIN I INCREASED |
9 |
0.0054 |
| 278 |
TONIC CLONIC MOVEMENTS |
7 |
0.0054 |
| 279 |
RESPIRATORY FAILURE |
392 |
0.0054 |
| 280 |
CEREBRAL HAEMATOMA |
18 |
0.0054 |
| 281 |
CRYPTORCHISM |
6 |
0.0053 |
| 282 |
HYPOTENSION |
1070 |
0.0053 |
| 283 |
METABOLIC ENCEPHALOPATHY |
16 |
0.0053 |
| 284 |
ACUTE KIDNEY INJURY |
812 |
0.0053 |
| 285 |
MYOCLONIC EPILEPSY |
8 |
0.0053 |
| 286 |
RESPIRATORY SYMPTOM |
15 |
0.0053 |
| 287 |
MECHANICAL VENTILATION |
10 |
0.0053 |
| 288 |
FIXED ERUPTION |
9 |
0.0052 |
| 289 |
ELECTROCARDIOGRAM ABNORMAL |
41 |
0.0052 |
| 290 |
SPLENIC INFARCTION |
9 |
0.0052 |
| 291 |
SHOCK HAEMORRHAGIC |
42 |
0.0052 |
| 292 |
CARDIOMYOPATHY |
76 |
0.0051 |
| 293 |
PSEUDOMONAL SEPSIS |
9 |
0.0051 |
| 294 |
LEUKOCYTOSIS |
93 |
0.0051 |
| 295 |
HYPOTONIA NEONATAL |
8 |
0.0051 |
| 296 |
BRONCHOPULMONARY ASPERGILLOSIS |
39 |
0.0050 |
| 297 |
SEPSIS |
560 |
0.0050 |
| 298 |
HYPONATRAEMIA |
282 |
0.0050 |
| 299 |
ENTEROCOCCAL INFECTION |
24 |
0.0050 |
| 300 |
HYPOTHERMIA |
50 |
0.0049 |
| 301 |
SINUS TACHYCARDIA |
70 |
0.0049 |
| 302 |
PULMONARY ARTERIAL PRESSURE INCREASED |
8 |
0.0049 |
| 303 |
BREATH SOUNDS ABNORMAL |
24 |
0.0049 |
| 304 |
EXTRAVASATION |
20 |
0.0049 |
| 305 |
RETROPERITONEAL HAEMORRHAGE |
12 |
0.0049 |
| 306 |
NECROSIS |
27 |
0.0048 |
| 307 |
HYPERTHERMIA |
37 |
0.0048 |
| 308 |
DEVICE INFUSION ISSUE |
12 |
0.0048 |
| 309 |
RENAL INFARCT |
7 |
0.0048 |
| 310 |
CAPILLARY LEAK SYNDROME |
10 |
0.0048 |
| 311 |
CARDIAC DYSFUNCTION |
18 |
0.0048 |
| 312 |
SYSTEMIC INFECTION |
8 |
0.0048 |
| 313 |
TACHYARRHYTHMIA |
12 |
0.0048 |
| 314 |
CONSCIOUSNESS FLUCTUATING |
5 |
0.0048 |
| 315 |
HEPATORENAL SYNDROME |
8 |
0.0047 |
| 316 |
TROPONIN T INCREASED |
6 |
0.0047 |
| 317 |
COMA |
225 |
0.0047 |
| 318 |
CARDIAC VENTRICULAR THROMBOSIS |
6 |
0.0046 |
| 319 |
DACRYOSTENOSIS ACQUIRED |
6 |
0.0046 |
| 320 |
BENIGN PROSTATIC HYPERPLASIA |
24 |
0.0046 |
| 321 |
RHABDOMYOLYSIS |
193 |
0.0046 |
| 322 |
INTRA-ABDOMINAL HAEMORRHAGE |
11 |
0.0046 |
| 323 |
DRUG CLEARANCE DECREASED |
6 |
0.0046 |
| 324 |
ARRHYTHMIA SUPRAVENTRICULAR |
5 |
0.0046 |
| 325 |
PNEUMONIA STAPHYLOCOCCAL |
9 |
0.0046 |
| 326 |
NECROTISING FASCIITIS |
16 |
0.0045 |
| 327 |
RETROPERITONEAL HAEMATOMA |
10 |
0.0045 |
| 328 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
16 |
0.0045 |
| 329 |
BUNDLE BRANCH BLOCK LEFT |
19 |
0.0045 |
| 330 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
17 |
0.0044 |
| 331 |
CYTOKINE RELEASE SYNDROME |
89 |
0.0044 |
| 332 |
HYPERLIPIDAEMIA |
53 |
0.0044 |
| 333 |
CARDIAC TAMPONADE |
21 |
0.0044 |
| 334 |
INTERMITTENT CLAUDICATION |
7 |
0.0044 |
| 335 |
ORTHOPNOEA |
14 |
0.0044 |
| 336 |
CHOLESTASIS |
84 |
0.0044 |
| 337 |
IMMUNE THROMBOCYTOPENIA |
20 |
0.0044 |
| 338 |
DIFFUSE ALVEOLAR DAMAGE |
5 |
0.0043 |
| 339 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
238 |
0.0043 |
| 340 |
BLOOD CALCIUM INCREASED |
38 |
0.0043 |
| 341 |
RESPIRATORY ALKALOSIS |
7 |
0.0043 |
| 342 |
OPTIC ATROPHY |
7 |
0.0043 |
| 343 |
CARDIAC FAILURE ACUTE |
28 |
0.0042 |
| 344 |
PREMATURE BABY |
125 |
0.0041 |
| 345 |
CHRONIC RESPIRATORY FAILURE |
5 |
0.0041 |
| 346 |
TACHYPNOEA |
56 |
0.0041 |
| 347 |
END STAGE RENAL DISEASE |
75 |
0.0041 |
| 348 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
12 |
0.0041 |
| 349 |
CARDIOPULMONARY FAILURE |
16 |
0.0041 |
| 350 |
PNEUMONIA FUNGAL |
16 |
0.0041 |
| 351 |
VENOOCCLUSIVE LIVER DISEASE |
20 |
0.0040 |
| 352 |
MULTI-ORGAN FAILURE |
70 |
0.0040 |
| 353 |
NEURALGIA |
98 |
0.0040 |
| 354 |
DRUG LEVEL BELOW THERAPEUTIC |
22 |
0.0040 |
| 355 |
BRAIN OEDEMA |
50 |
0.0040 |
| 356 |
VASCULAR STENT THROMBOSIS |
8 |
0.0039 |
| 357 |
ASPIRATION |
43 |
0.0039 |
| 358 |
HYPERKALAEMIA |
137 |
0.0039 |
| 359 |
TOXICITY TO VARIOUS AGENTS |
658 |
0.0039 |
| 360 |
COAGULATION TIME PROLONGED |
6 |
0.0039 |
| 361 |
SKIN NECROSIS |
20 |
0.0039 |
| 362 |
VENTRICULAR DYSFUNCTION |
10 |
0.0039 |
| 363 |
COLITIS ISCHAEMIC |
26 |
0.0039 |
| 364 |
CLOSTRIDIAL INFECTION |
13 |
0.0038 |
| 365 |
HEART VALVE INCOMPETENCE |
11 |
0.0038 |
| 366 |
DEVICE CONNECTION ISSUE |
8 |
0.0038 |
| 367 |
INHIBITORY DRUG INTERACTION |
6 |
0.0038 |
| 368 |
RALES |
22 |
0.0038 |
| 369 |
PUPILLARY REFLEX IMPAIRED |
7 |
0.0038 |
| 370 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
8 |
0.0038 |
| 371 |
HYPERTRIGLYCERIDAEMIA |
22 |
0.0038 |
| 372 |
ATRIOVENTRICULAR BLOCK |
29 |
0.0037 |
| 373 |
TUMOUR LYSIS SYNDROME |
33 |
0.0037 |
| 374 |
AREFLEXIA |
10 |
0.0037 |
| 375 |
PULMONARY ALVEOLAR HAEMORRHAGE |
21 |
0.0037 |
| 376 |
ATRIOVENTRICULAR BLOCK COMPLETE |
25 |
0.0037 |
| 377 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
28 |
0.0037 |
| 378 |
BACTERAEMIA |
44 |
0.0037 |
| 379 |
BACTERIAL SEPSIS |
12 |
0.0037 |
| 380 |
STAPHYLOCOCCAL BACTERAEMIA |
16 |
0.0037 |
| 381 |
FIBRIN D DIMER INCREASED |
13 |
0.0037 |
| 382 |
CLONUS |
10 |
0.0037 |
| 383 |
BRADYARRHYTHMIA |
6 |
0.0036 |
| 384 |
TYPE IV HYPERSENSITIVITY REACTION |
10 |
0.0036 |
| 385 |
GENERALISED TONIC-CLONIC SEIZURE |
60 |
0.0036 |
| 386 |
PATHOGEN RESISTANCE |
33 |
0.0036 |
| 387 |
ELECTROCARDIOGRAM T WAVE INVERSION |
8 |
0.0036 |
| 388 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
7 |
0.0036 |
| 389 |
MYOCARDIAL NECROSIS MARKER INCREASED |
6 |
0.0036 |
| 390 |
ACUTE PULMONARY OEDEMA |
20 |
0.0036 |
| 391 |
CELL DEATH |
7 |
0.0035 |
| 392 |
SEDATION COMPLICATION |
9 |
0.0035 |
| 393 |
OXYGEN SATURATION ABNORMAL |
10 |
0.0035 |
| 394 |
CARDIAC FAILURE CHRONIC |
15 |
0.0035 |
| 395 |
BRAIN INJURY |
35 |
0.0035 |
| 396 |
RECALLED PRODUCT |
6 |
0.0035 |
| 397 |
TRANSAMINASES INCREASED |
77 |
0.0035 |
| 398 |
ENCEPHALOPATHY |
85 |
0.0035 |
| 399 |
HEPATIC CYTOLYSIS |
44 |
0.0034 |
| 400 |
LIVER FUNCTION TEST INCREASED |
74 |
0.0034 |
| 401 |
MYDRIASIS |
44 |
0.0034 |
| 402 |
STRIDOR |
10 |
0.0034 |
| 403 |
HYPERBILIRUBINAEMIA |
35 |
0.0034 |
| 404 |
TACHYCARDIA |
296 |
0.0033 |
| 405 |
PULMONARY HAEMORRHAGE |
26 |
0.0033 |
| 406 |
HYPERTRANSAMINASAEMIA |
23 |
0.0033 |
| 407 |
PULMONARY OEDEMA |
148 |
0.0033 |
| 408 |
ESCHERICHIA INFECTION |
27 |
0.0033 |
| 409 |
CONDUCTION DISORDER |
6 |
0.0033 |
| 410 |
ULCER |
52 |
0.0033 |
| 411 |
BUNDLE BRANCH BLOCK RIGHT |
15 |
0.0033 |
| 412 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
5 |
0.0033 |
| 413 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
31 |
0.0032 |
| 414 |
STAPHYLOCOCCAL SEPSIS |
16 |
0.0032 |
| 415 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
127 |
0.0032 |
| 416 |
LEFT VENTRICULAR FAILURE |
11 |
0.0032 |
| 417 |
ACUTE HEPATIC FAILURE |
43 |
0.0031 |
| 418 |
HYPOVOLAEMIC SHOCK |
15 |
0.0031 |
| 419 |
HAEMOLYSIS |
24 |
0.0031 |
| 420 |
ARTERIAL THROMBOSIS |
6 |
0.0031 |
| 421 |
STATUS EPILEPTICUS |
35 |
0.0031 |
| 422 |
ESCHERICHIA URINARY TRACT INFECTION |
13 |
0.0031 |
| 423 |
DRUG LEVEL ABOVE THERAPEUTIC |
14 |
0.0031 |
| 424 |
HEPATITIS FULMINANT |
9 |
0.0030 |
| 425 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
10 |
0.0030 |
| 426 |
NEUROLOGICAL DECOMPENSATION |
7 |
0.0030 |
| 427 |
THERAPY NON-RESPONDER |
135 |
0.0030 |
| 428 |
HYPERAMMONAEMIA |
15 |
0.0030 |
| 429 |
HEPATIC FAILURE |
90 |
0.0030 |
| 430 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
9 |
0.0030 |
| 431 |
GOUT |
53 |
0.0030 |
| 432 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
9 |
0.0029 |
| 433 |
POLYCYTHAEMIA |
6 |
0.0029 |
| 434 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
46 |
0.0029 |
| 435 |
ASPERGILLUS INFECTION |
19 |
0.0029 |
| 436 |
BLOOD CHLORIDE INCREASED |
5 |
0.0029 |
| 437 |
ATRIAL FLUTTER |
23 |
0.0029 |
| 438 |
DERMATITIS EXFOLIATIVE GENERALISED |
10 |
0.0029 |
| 439 |
LUNG CONSOLIDATION |
8 |
0.0029 |
| 440 |
MYOCLONUS |
34 |
0.0028 |
| 441 |
INFLAMMATORY MARKER INCREASED |
14 |
0.0028 |
| 442 |
BRONCHIECTASIS |
19 |
0.0028 |
| 443 |
ILEUS |
35 |
0.0028 |
| 444 |
PROCEDURAL HAEMORRHAGE |
11 |
0.0028 |
| 445 |
MYOCARDIAL ISCHAEMIA |
32 |
0.0028 |
| 446 |
ANAEMIA MACROCYTIC |
6 |
0.0028 |
| 447 |
PULMONARY CONGESTION |
37 |
0.0028 |
| 448 |
NEPHROGENIC ANAEMIA |
13 |
0.0028 |
| 449 |
AORTIC VALVE STENOSIS |
5 |
0.0028 |
| 450 |
ATELECTASIS |
27 |
0.0028 |
| 451 |
CANDIDA INFECTION |
47 |
0.0028 |
| 452 |
DEVICE ALARM ISSUE |
5 |
0.0028 |
| 453 |
THROMBOSIS IN DEVICE |
9 |
0.0027 |
| 454 |
URINE OUTPUT DECREASED |
24 |
0.0027 |
| 455 |
HEPATOTOXICITY |
61 |
0.0027 |
| 456 |
MITRAL VALVE INCOMPETENCE |
31 |
0.0027 |
| 457 |
PULMONARY HYPERTENSION |
57 |
0.0027 |
| 458 |
PRODUCT PACKAGING ISSUE |
26 |
0.0027 |
| 459 |
GRAFT VERSUS HOST DISEASE IN SKIN |
6 |
0.0027 |
| 460 |
PSEUDOMEMBRANOUS COLITIS |
6 |
0.0027 |
| 461 |
GASTROINTESTINAL HYPOMOTILITY |
6 |
0.0027 |
| 462 |
NEUTROPENIC SEPSIS |
19 |
0.0027 |
| 463 |
MENTAL STATUS CHANGES |
73 |
0.0026 |
| 464 |
OBSTRUCTIVE AIRWAYS DISORDER |
29 |
0.0026 |
| 465 |
CARDIO-RESPIRATORY ARREST |
109 |
0.0026 |
| 466 |
DRUG LEVEL INCREASED |
43 |
0.0026 |
| 467 |
HAEMANGIOMA |
6 |
0.0026 |
| 468 |
DIASTOLIC DYSFUNCTION |
8 |
0.0026 |
| 469 |
BLOOD POTASSIUM INCREASED |
42 |
0.0026 |
| 470 |
RESPIRATORY DISTRESS |
71 |
0.0026 |
| 471 |
HYPOVOLAEMIA |
15 |
0.0026 |
| 472 |
ACUTE CORONARY SYNDROME |
21 |
0.0025 |
| 473 |
EJECTION FRACTION DECREASED |
39 |
0.0025 |
| 474 |
DELIRIUM |
87 |
0.0025 |
| 475 |
ASPARTATE AMINOTRANSFERASE INCREASED |
133 |
0.0025 |
| 476 |
VENTRICULAR EXTRASYSTOLES |
26 |
0.0025 |
| 477 |
ENDOTRACHEAL INTUBATION |
7 |
0.0025 |
| 478 |
BLOOD TEST ABNORMAL |
35 |
0.0025 |
| 479 |
BLOOD CREATINE INCREASED |
11 |
0.0025 |
| 480 |
PRODUCT PACKAGING CONFUSION |
6 |
0.0025 |
| 481 |
COVID-19 PNEUMONIA |
29 |
0.0025 |
| 482 |
THROMBOCYTOSIS |
9 |
0.0025 |
| 483 |
BLOOD CHOLESTEROL INCREASED |
114 |
0.0024 |
| 484 |
DIVERTICULAR PERFORATION |
5 |
0.0024 |
| 485 |
RASH MACULO-PAPULAR |
54 |
0.0024 |
| 486 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
10 |
0.0024 |
| 487 |
GENERAL PHYSICAL HEALTH DETERIORATION |
280 |
0.0024 |
| 488 |
INTRAVENTRICULAR HAEMORRHAGE |
6 |
0.0024 |
| 489 |
ALANINE AMINOTRANSFERASE INCREASED |
147 |
0.0024 |
| 490 |
HEPATIC NECROSIS |
9 |
0.0024 |
| 491 |
DILATATION VENTRICULAR |
5 |
0.0024 |
| 492 |
ABDOMINAL DISTENSION |
248 |
0.0024 |
| 493 |
PROTHROMBIN TIME PROLONGED |
14 |
0.0023 |
| 494 |
DISSEMINATED TUBERCULOSIS |
6 |
0.0023 |
| 495 |
BLOOD CREATININE INCREASED |
152 |
0.0023 |
| 496 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
67 |
0.0023 |
| 497 |
ANAPHYLACTIC SHOCK |
60 |
0.0023 |
| 498 |
SPUTUM DISCOLOURED |
22 |
0.0023 |
| 499 |
HYPOALBUMINAEMIA |
18 |
0.0023 |
| 500 |
VENOUS THROMBOSIS |
9 |
0.0023 |
| 501 |
PNEUMONIA ASPIRATION |
57 |
0.0023 |
| 502 |
NYSTAGMUS |
12 |
0.0023 |
| 503 |
MULTIPLE-DRUG RESISTANCE |
7 |
0.0023 |
| 504 |
CHOLESTATIC LIVER INJURY |
5 |
0.0022 |
| 505 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
117 |
0.0022 |
| 506 |
ILEUS PARALYTIC |
10 |
0.0022 |
| 507 |
RESPIRATORY RATE DECREASED |
7 |
0.0022 |
| 508 |
NEPHROPATHY TOXIC |
25 |
0.0022 |
| 509 |
EOSINOPHILIA |
39 |
0.0022 |
| 510 |
EOSINOPHILIC PNEUMONIA |
7 |
0.0022 |
| 511 |
INFARCTION |
15 |
0.0022 |
| 512 |
THROMBOCYTOPENIA |
245 |
0.0022 |
| 513 |
PNEUMONIA BACTERIAL |
20 |
0.0022 |
| 514 |
PARADOXICAL DRUG REACTION |
8 |
0.0022 |
| 515 |
AMMONIA INCREASED |
11 |
0.0022 |
| 516 |
PNEUMOTHORAX |
34 |
0.0021 |
| 517 |
HAEMODIALYSIS |
18 |
0.0021 |
| 518 |
DRUG INTERACTION |
340 |
0.0021 |
| 519 |
FOETAL GROWTH RESTRICTION |
13 |
0.0021 |
| 520 |
BLOOD PRESSURE DECREASED |
142 |
0.0021 |
| 521 |
TUMOUR HAEMORRHAGE |
6 |
0.0021 |
| 522 |
UNRESPONSIVE TO STIMULI |
54 |
0.0021 |
| 523 |
SPEECH DISORDER DEVELOPMENTAL |
6 |
0.0021 |
| 524 |
BLOOD UREA INCREASED |
35 |
0.0021 |
| 525 |
PLEURAL EFFUSION |
127 |
0.0021 |
| 526 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
35 |
0.0021 |
| 527 |
ALTERED STATE OF CONSCIOUSNESS |
45 |
0.0021 |
| 528 |
CLOSTRIDIUM DIFFICILE COLITIS |
22 |
0.0021 |
| 529 |
BLOOD BILIRUBIN INCREASED |
56 |
0.0021 |
| 530 |
ESCHERICHIA SEPSIS |
6 |
0.0021 |
| 531 |
SKIN WARM |
12 |
0.0021 |
| 532 |
ADRENAL INSUFFICIENCY |
25 |
0.0021 |
| 533 |
RENAL IMPAIRMENT |
173 |
0.0021 |
| 534 |
FOETAL EXPOSURE DURING PREGNANCY |
165 |
0.0020 |
| 535 |
CREPITATIONS |
6 |
0.0020 |
| 536 |
SMALL FOR DATES BABY |
10 |
0.0020 |
| 537 |
MICTURITION URGENCY |
23 |
0.0020 |
| 538 |
SUICIDE ATTEMPT |
122 |
0.0020 |
| 539 |
HYPERREFLEXIA |
7 |
0.0020 |
| 540 |
MIXED LIVER INJURY |
6 |
0.0020 |
| 541 |
ORGAN FAILURE |
8 |
0.0020 |
| 542 |
JAUNDICE CHOLESTATIC |
7 |
0.0020 |
| 543 |
CONDITION AGGRAVATED |
599 |
0.0020 |
| 544 |
UROSEPSIS |
18 |
0.0019 |
| 545 |
HYPOKALAEMIA |
90 |
0.0019 |
| 546 |
ENDOCARDITIS |
10 |
0.0019 |
| 547 |
PORTAL HYPERTENSION |
6 |
0.0019 |
| 548 |
HYPERCALCAEMIA |
24 |
0.0019 |
| 549 |
CEREBRAL ISCHAEMIA |
10 |
0.0019 |
| 550 |
DRUG INEFFECTIVE |
2543 |
0.0019 |
| 551 |
FOETAL DEATH |
10 |
0.0019 |
| 552 |
PULMONARY EMBOLISM |
183 |
0.0019 |
| 553 |
NERVOUS SYSTEM DISORDER |
60 |
0.0019 |
| 554 |
CONGESTIVE CARDIOMYOPATHY |
8 |
0.0019 |
| 555 |
RENAL FAILURE |
253 |
0.0019 |
| 556 |
ELECTROLYTE IMBALANCE |
22 |
0.0019 |
| 557 |
POST PROCEDURAL HAEMORRHAGE |
22 |
0.0019 |
| 558 |
POOR PERIPHERAL CIRCULATION |
8 |
0.0019 |
| 559 |
SUBARACHNOID HAEMORRHAGE |
19 |
0.0019 |
| 560 |
HAEMOPTYSIS |
52 |
0.0019 |
| 561 |
ANAESTHETIC COMPLICATION |
5 |
0.0019 |
| 562 |
POSTURE ABNORMAL |
6 |
0.0018 |
| 563 |
HYPOVENTILATION |
6 |
0.0018 |
| 564 |
POLYURIA |
15 |
0.0018 |
| 565 |
DERMATITIS BULLOUS |
13 |
0.0018 |
| 566 |
ERYSIPELAS |
9 |
0.0018 |
| 567 |
CORONARY ARTERY STENOSIS |
9 |
0.0018 |
| 568 |
INTENTIONAL PRODUCT MISUSE |
156 |
0.0018 |
| 569 |
GENERALISED OEDEMA |
22 |
0.0018 |
| 570 |
AZOTAEMIA |
7 |
0.0018 |
| 571 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
6 |
0.0017 |
| 572 |
ENCEPHALITIS |
12 |
0.0017 |
| 573 |
APLASTIC ANAEMIA |
9 |
0.0017 |
| 574 |
STEVENS-JOHNSON SYNDROME |
38 |
0.0017 |
| 575 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
6 |
0.0017 |
| 576 |
PRE-ECLAMPSIA |
8 |
0.0017 |
| 577 |
MATERNAL EXPOSURE DURING PREGNANCY |
150 |
0.0017 |
| 578 |
PULMONARY MASS |
25 |
0.0017 |
| 579 |
LIVER INJURY |
41 |
0.0017 |
| 580 |
HYPOGLYCAEMIA |
81 |
0.0017 |
| 581 |
DRY MOUTH |
135 |
0.0017 |
| 582 |
EXPOSURE DURING PREGNANCY |
103 |
0.0017 |
| 583 |
INCORRECT DRUG ADMINISTRATION RATE |
7 |
0.0016 |
| 584 |
THROMBOSIS |
131 |
0.0016 |
| 585 |
TRANSFUSION |
17 |
0.0016 |
| 586 |
INTRACRANIAL PRESSURE INCREASED |
9 |
0.0016 |
| 587 |
CARDIOVASCULAR DISORDER |
41 |
0.0016 |
| 588 |
CHOLANGITIS |
10 |
0.0016 |
| 589 |
HEPATIC FUNCTION ABNORMAL |
60 |
0.0016 |
| 590 |
FULL BLOOD COUNT ABNORMAL |
17 |
0.0016 |
| 591 |
STAPHYLOCOCCAL INFECTION |
53 |
0.0016 |
| 592 |
ANGIOPATHY |
9 |
0.0016 |
| 593 |
HYPOTONIA |
16 |
0.0016 |
| 594 |
NEUROTOXICITY |
28 |
0.0016 |
| 595 |
DECUBITUS ULCER |
13 |
0.0016 |
| 596 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
16 |
0.0016 |
| 597 |
PULMONARY ARTERIAL HYPERTENSION |
23 |
0.0016 |
| 598 |
LARGE INTESTINE PERFORATION |
11 |
0.0016 |
| 599 |
VENTRICULAR SEPTAL DEFECT |
9 |
0.0016 |
| 600 |
EMBOLISM |
13 |
0.0016 |
| 601 |
AGRANULOCYTOSIS |
29 |
0.0016 |
| 602 |
CLOSTRIDIUM DIFFICILE INFECTION |
34 |
0.0016 |
| 603 |
PERICARDIAL EFFUSION |
36 |
0.0016 |
| 604 |
FEBRILE NEUTROPENIA |
103 |
0.0016 |
| 605 |
DIABETES MELLITUS |
118 |
0.0015 |
| 606 |
RHINOVIRUS INFECTION |
6 |
0.0015 |
| 607 |
BLOOD PRESSURE SYSTOLIC DECREASED |
7 |
0.0015 |
| 608 |
FLUID OVERLOAD |
22 |
0.0015 |
| 609 |
MOUTH HAEMORRHAGE |
11 |
0.0015 |
| 610 |
MUSCLE HAEMORRHAGE |
6 |
0.0015 |
| 611 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
11 |
0.0015 |
| 612 |
MYOCARDITIS |
17 |
0.0015 |
| 613 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
6 |
0.0015 |
| 614 |
NORMAL NEWBORN |
8 |
0.0015 |
| 615 |
ANAPHYLACTOID REACTION |
6 |
0.0015 |
| 616 |
LEG AMPUTATION |
6 |
0.0015 |
| 617 |
HYPERGLYCAEMIA |
53 |
0.0015 |
| 618 |
HYPERCHOLESTEROLAEMIA |
14 |
0.0014 |
| 619 |
PERITONITIS |
30 |
0.0014 |
| 620 |
GUILLAIN-BARRE SYNDROME |
7 |
0.0014 |
| 621 |
OVERDOSE |
312 |
0.0014 |
| 622 |
DRUG RESISTANCE |
37 |
0.0014 |
| 623 |
LIVE BIRTH |
12 |
0.0014 |
| 624 |
ANAPHYLACTIC REACTION |
79 |
0.0014 |
| 625 |
HYPOCALCAEMIA |
27 |
0.0014 |
| 626 |
DUODENAL ULCER |
10 |
0.0014 |
| 627 |
CHOLECYSTITIS ACUTE |
8 |
0.0014 |
| 628 |
AORTIC VALVE INCOMPETENCE |
6 |
0.0014 |
| 629 |
ABDOMINAL TENDERNESS |
7 |
0.0014 |
| 630 |
DIALYSIS |
20 |
0.0014 |
| 631 |
HYPOPHAGIA |
36 |
0.0014 |
| 632 |
PULMONARY TUBERCULOSIS |
6 |
0.0014 |
| 633 |
CARDIAC FAILURE |
112 |
0.0014 |
| 634 |
PRODUCT ADMINISTRATION ERROR |
28 |
0.0014 |
| 635 |
TRICUSPID VALVE INCOMPETENCE |
11 |
0.0014 |
| 636 |
DRUG LEVEL DECREASED |
14 |
0.0014 |
| 637 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
7 |
0.0014 |
| 638 |
BLOOD DISORDER |
11 |
0.0014 |
| 639 |
PRODUCT USE IN UNAPPROVED INDICATION |
339 |
0.0014 |
| 640 |
LUNG INFILTRATION |
12 |
0.0014 |
| 641 |
ACUTE MYOCARDIAL INFARCTION |
40 |
0.0014 |
| 642 |
NEUROLEPTIC MALIGNANT SYNDROME |
16 |
0.0013 |
| 643 |
OFF LABEL USE |
1174 |
0.0013 |
| 644 |
HAEMOLYTIC ANAEMIA |
12 |
0.0013 |
| 645 |
MUSCLE RIGIDITY |
16 |
0.0013 |
| 646 |
HAEMORRHAGE INTRACRANIAL |
20 |
0.0013 |
| 647 |
INTESTINAL PERFORATION |
15 |
0.0013 |
| 648 |
HYPOKINESIA |
19 |
0.0013 |
| 649 |
SLEEP DISORDER |
92 |
0.0013 |
| 650 |
ABDOMINAL PAIN |
302 |
0.0013 |
| 651 |
INTERNATIONAL NORMALISED RATIO INCREASED |
37 |
0.0013 |
| 652 |
ATRIAL FIBRILLATION |
125 |
0.0013 |
| 653 |
HAEMORRHAGIC STROKE |
10 |
0.0013 |
| 654 |
ABORTION INDUCED |
12 |
0.0013 |
| 655 |
LYMPHOPENIA |
18 |
0.0013 |
| 656 |
RENAL FAILURE ACUTE |
54 |
0.0013 |
| 657 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
13 |
0.0013 |
| 658 |
CYTOMEGALOVIRUS INFECTION |
21 |
0.0013 |
| 659 |
HYPERTENSIVE CRISIS |
14 |
0.0013 |
| 660 |
PARALYSIS |
18 |
0.0013 |
| 661 |
PULMONARY FIBROSIS |
24 |
0.0012 |
| 662 |
TRANSPLANT REJECTION |
10 |
0.0012 |
| 663 |
ARRHYTHMIA |
59 |
0.0012 |
| 664 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
11 |
0.0012 |
| 665 |
ANAEMIA |
237 |
0.0012 |
| 666 |
HAEMATOMA |
32 |
0.0012 |
| 667 |
ACCIDENTAL OVERDOSE |
45 |
0.0012 |
| 668 |
SEIZURE |
142 |
0.0012 |
| 669 |
GLOMERULAR FILTRATION RATE DECREASED |
15 |
0.0012 |
| 670 |
PANCYTOPENIA |
68 |
0.0012 |
| 671 |
ENTEROCOLITIS |
7 |
0.0012 |
| 672 |
METABOLIC DISORDER |
7 |
0.0012 |
| 673 |
LEUKOPENIA |
60 |
0.0012 |
| 674 |
TOXIC SKIN ERUPTION |
12 |
0.0012 |
| 675 |
CONJUNCTIVITIS |
22 |
0.0012 |
| 676 |
BODY TEMPERATURE INCREASED |
24 |
0.0012 |
| 677 |
SWELLING |
110 |
0.0012 |
| 678 |
PROCEDURAL COMPLICATION |
9 |
0.0012 |
| 679 |
AGITATION |
86 |
0.0012 |
| 680 |
DIFFUSE LARGE B-CELL LYMPHOMA |
9 |
0.0012 |
| 681 |
HEPATITIS CHOLESTATIC |
7 |
0.0012 |
| 682 |
MYOPATHY |
10 |
0.0012 |
| 683 |
DERMATITIS ACNEIFORM |
7 |
0.0011 |
| 684 |
CEREBRAL INFARCTION |
28 |
0.0011 |
| 685 |
CYANOSIS |
18 |
0.0011 |
| 686 |
CARDIOMEGALY |
14 |
0.0011 |
| 687 |
INJECTION SITE EXTRAVASATION |
14 |
0.0011 |
| 688 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
5 |
0.0011 |
| 689 |
HEPATOCELLULAR INJURY |
16 |
0.0011 |
| 690 |
INFUSION SITE EXTRAVASATION |
7 |
0.0011 |
| 691 |
JOINT INJURY |
24 |
0.0011 |
| 692 |
CORONARY ARTERY DISEASE |
34 |
0.0011 |
| 693 |
SOMNOLENCE |
226 |
0.0011 |
| 694 |
HEPATOMEGALY |
11 |
0.0011 |
| 695 |
OVERWEIGHT |
6 |
0.0011 |
| 696 |
DRUG INTOLERANCE |
107 |
0.0011 |
| 697 |
CHROMATURIA |
25 |
0.0011 |
| 698 |
HYDROCEPHALUS |
6 |
0.0011 |
| 699 |
CONSTIPATION |
239 |
0.0011 |
| 700 |
ENTERITIS |
7 |
0.0011 |
| 701 |
ACUTE GRAFT VERSUS HOST DISEASE |
5 |
0.0011 |
| 702 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
27 |
0.0011 |
| 703 |
HEPATIC ENCEPHALOPATHY |
10 |
0.0011 |
| 704 |
UPPER RESPIRATORY TRACT INFECTION |
49 |
0.0011 |
| 705 |
HAEMATOCRIT DECREASED |
21 |
0.0011 |
| 706 |
PRODUCT PRESCRIBING ISSUE |
23 |
0.0011 |
| 707 |
HYPERTONIA |
6 |
0.0010 |
| 708 |
MELAENA |
23 |
0.0010 |
| 709 |
MOUTH ULCERATION |
22 |
0.0010 |
| 710 |
JAUNDICE |
28 |
0.0010 |
| 711 |
LIVER DISORDER |
46 |
0.0010 |
| 712 |
CONGENITAL ANOMALY |
8 |
0.0010 |
| 713 |
PRODUCT LABEL CONFUSION |
6 |
0.0010 |
| 714 |
PNEUMONITIS |
28 |
0.0010 |
| 715 |
PURPURA |
9 |
0.0010 |
| 716 |
RESPIRATION ABNORMAL |
7 |
0.0010 |
| 717 |
RESPIRATORY RATE INCREASED |
9 |
0.0010 |
| 718 |
LOWER RESPIRATORY TRACT INFECTION |
46 |
0.0010 |
| 719 |
ISCHAEMIC STROKE |
18 |
0.0010 |
| 720 |
BLOOD ALBUMIN DECREASED |
8 |
0.0010 |
| 721 |
HYPOMAGNESAEMIA |
14 |
0.0010 |
| 722 |
EXTRASYSTOLES |
7 |
0.0010 |
| 723 |
PNEUMONIA |
323 |
0.0010 |
| 724 |
INGUINAL HERNIA |
6 |
0.0010 |
| 725 |
MALNUTRITION |
11 |
0.0010 |
| 726 |
GASTROINTESTINAL HAEMORRHAGE |
82 |
0.0010 |
| 727 |
BRONCHOSPASM |
14 |
0.0010 |
| 728 |
BLISTER |
55 |
0.0010 |
| 729 |
SUBDURAL HAEMATOMA |
14 |
0.0010 |
| 730 |
RESPIRATORY DISORDER |
29 |
0.0010 |
| 731 |
C-REACTIVE PROTEIN INCREASED |
35 |
0.0010 |
| 732 |
POST PROCEDURAL COMPLICATION |
18 |
0.0009 |
| 733 |
HERPES SIMPLEX |
6 |
0.0009 |
| 734 |
OXYGEN SATURATION DECREASED |
51 |
0.0009 |
| 735 |
DEAFNESS UNILATERAL |
5 |
0.0009 |
| 736 |
LUNG INFECTION |
14 |
0.0009 |
| 737 |
GASTRIC ULCER |
17 |
0.0009 |
| 738 |
CEREBRAL HAEMORRHAGE |
32 |
0.0009 |
| 739 |
MYOSITIS |
8 |
0.0009 |
| 740 |
PLATELET COUNT DECREASED |
95 |
0.0009 |
| 741 |
REBOUND EFFECT |
10 |
0.0009 |
| 742 |
ABNORMAL LOSS OF WEIGHT |
6 |
0.0009 |
| 743 |
LUNG DISORDER |
43 |
0.0009 |
| 744 |
ECCHYMOSIS |
6 |
0.0009 |
| 745 |
PERIPHERAL COLDNESS |
12 |
0.0009 |
| 746 |
SPINAL PAIN |
10 |
0.0009 |
| 747 |
ARTERIOSCLEROSIS |
8 |
0.0008 |
| 748 |
DRUG ERUPTION |
15 |
0.0008 |
| 749 |
PANCREATITIS ACUTE |
19 |
0.0008 |
| 750 |
ATRIAL SEPTAL DEFECT |
7 |
0.0008 |
| 751 |
POLYNEUROPATHY |
10 |
0.0008 |
| 752 |
CHRONIC KIDNEY DISEASE |
63 |
0.0008 |
| 753 |
DRUG-INDUCED LIVER INJURY |
26 |
0.0008 |
| 754 |
HAEMORRHAGE |
86 |
0.0008 |
| 755 |
COLITIS |
31 |
0.0008 |
| 756 |
LETHARGY |
47 |
0.0008 |
| 757 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
18 |
0.0008 |
| 758 |
DRUG DIVERSION |
5 |
0.0008 |
| 759 |
TREATMENT FAILURE |
67 |
0.0008 |
| 760 |
NEUTROPHIL COUNT DECREASED |
32 |
0.0008 |
| 761 |
MOTOR DYSFUNCTION |
8 |
0.0008 |
| 762 |
RENAL INJURY |
23 |
0.0008 |
| 763 |
PALLOR |
21 |
0.0008 |
| 764 |
HAEMOGLOBIN DECREASED |
79 |
0.0008 |
| 765 |
HYPERTENSION |
162 |
0.0008 |
| 766 |
PYREXIA |
264 |
0.0008 |
| 767 |
IRON DEFICIENCY ANAEMIA |
7 |
0.0008 |
| 768 |
CHOLECYSTITIS |
9 |
0.0008 |
| 769 |
GASTROENTERITIS |
11 |
0.0008 |
| 770 |
ERYTHEMA MULTIFORME |
7 |
0.0007 |
| 771 |
VOMITING |
346 |
0.0007 |
| 772 |
CYTOPENIA |
9 |
0.0007 |
| 773 |
ASPHYXIA |
6 |
0.0007 |
| 774 |
HEMIPLEGIA |
6 |
0.0007 |
| 775 |
HEPATIC ENZYME INCREASED |
49 |
0.0007 |
| 776 |
DISEASE PROGRESSION |
85 |
0.0007 |
| 777 |
TRANSIENT ISCHAEMIC ATTACK |
24 |
0.0007 |
| 778 |
THERAPY PARTIAL RESPONDER |
11 |
0.0007 |
| 779 |
BLOOD PRESSURE ABNORMAL |
14 |
0.0007 |
| 780 |
TUBULOINTERSTITIAL NEPHRITIS |
13 |
0.0007 |
| 781 |
CONTRAINDICATED PRODUCT ADMINISTERED |
21 |
0.0007 |
| 782 |
PYELONEPHRITIS |
6 |
0.0007 |
| 783 |
LIVER FUNCTION TEST ABNORMAL |
20 |
0.0007 |
| 784 |
ORAL CANDIDIASIS |
9 |
0.0007 |
| 785 |
LYMPHOCYTE COUNT DECREASED |
12 |
0.0007 |
| 786 |
ANGIOEDEMA |
30 |
0.0007 |
| 787 |
HAEMATEMESIS |
17 |
0.0007 |
| 788 |
OPTIC NEURITIS |
6 |
0.0007 |
| 789 |
WHITE BLOOD CELL COUNT INCREASED |
25 |
0.0007 |
| 790 |
SMALL INTESTINAL OBSTRUCTION |
8 |
0.0006 |
| 791 |
PANCREATITIS |
34 |
0.0006 |
| 792 |
APNOEA |
5 |
0.0006 |
| 793 |
NEUTROPENIA |
87 |
0.0006 |
| 794 |
DEEP VEIN THROMBOSIS |
41 |
0.0006 |
| 795 |
OBESITY |
10 |
0.0006 |
| 796 |
OEDEMA PERIPHERAL |
75 |
0.0006 |
| 797 |
HAEMATURIA |
21 |
0.0006 |
| 798 |
ABNORMAL FAECES |
5 |
0.0006 |
| 799 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
9 |
0.0006 |
| 800 |
SARS-COV-2 TEST POSITIVE |
8 |
0.0006 |
| 801 |
VASCULITIS |
7 |
0.0006 |
| 802 |
SKIN DISORDER |
20 |
0.0006 |
| 803 |
OEDEMA |
32 |
0.0006 |
| 804 |
ATAXIA |
7 |
0.0006 |
| 805 |
DIABETIC KETOACIDOSIS |
14 |
0.0006 |
| 806 |
FUNGAL INFECTION |
19 |
0.0006 |
| 807 |
INCONTINENCE |
6 |
0.0006 |
| 808 |
ORAL HERPES |
11 |
0.0006 |
| 809 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
16 |
0.0005 |
| 810 |
HEART RATE INCREASED |
54 |
0.0005 |
| 811 |
RESPIRATORY ARREST |
15 |
0.0005 |
| 812 |
SKIN DISCOLOURATION |
25 |
0.0005 |
| 813 |
RASH ERYTHEMATOUS |
26 |
0.0005 |
| 814 |
CELLULITIS |
27 |
0.0005 |
| 815 |
HEMIPARESIS |
9 |
0.0005 |
| 816 |
DEVICE FAILURE |
8 |
0.0005 |
| 817 |
EPILEPSY |
16 |
0.0005 |
| 818 |
LOSS OF CONSCIOUSNESS |
67 |
0.0005 |
| 819 |
GASTRIC HAEMORRHAGE |
6 |
0.0005 |
| 820 |
CAESAREAN SECTION |
6 |
0.0005 |
| 821 |
ACUTE MYELOID LEUKAEMIA |
8 |
0.0005 |
| 822 |
GINGIVAL BLEEDING |
7 |
0.0005 |
| 823 |
HEART RATE DECREASED |
18 |
0.0005 |
| 824 |
BLOOD TRIGLYCERIDES INCREASED |
9 |
0.0005 |
| 825 |
HEPATITIS |
13 |
0.0005 |
| 826 |
DISEASE RECURRENCE |
24 |
0.0005 |
| 827 |
INFLAMMATION |
26 |
0.0005 |
| 828 |
BLOOD POTASSIUM DECREASED |
15 |
0.0005 |
| 829 |
BONE MARROW FAILURE |
10 |
0.0005 |
| 830 |
IMMUNODEFICIENCY |
7 |
0.0005 |
| 831 |
HIATUS HERNIA |
6 |
0.0005 |
| 832 |
PLATELET COUNT INCREASED |
6 |
0.0005 |
| 833 |
DYSPNOEA |
259 |
0.0005 |
| 834 |
INTENTIONAL PRODUCT USE ISSUE |
40 |
0.0005 |
| 835 |
DEVICE RELATED INFECTION |
7 |
0.0005 |
| 836 |
COGNITIVE DISORDER |
21 |
0.0004 |
| 837 |
URINARY RETENTION |
15 |
0.0004 |
| 838 |
BLOOD CALCIUM DECREASED |
5 |
0.0004 |
| 839 |
COMPLETED SUICIDE |
37 |
0.0004 |
| 840 |
COVID-19 |
77 |
0.0004 |
| 841 |
RESTLESSNESS |
16 |
0.0004 |
| 842 |
MEDICATION ERROR |
24 |
0.0004 |
| 843 |
COORDINATION ABNORMAL |
6 |
0.0004 |
| 844 |
RASH MACULAR |
15 |
0.0004 |
| 845 |
PSYCHOMOTOR HYPERACTIVITY |
7 |
0.0004 |
| 846 |
FACE OEDEMA |
7 |
0.0004 |
| 847 |
MYELODYSPLASTIC SYNDROME |
6 |
0.0004 |
| 848 |
HYPERTHYROIDISM |
6 |
0.0004 |
| 849 |
COMPLICATION ASSOCIATED WITH DEVICE |
6 |
0.0004 |
| 850 |
MUSCULOSKELETAL STIFFNESS |
36 |
0.0004 |
| 851 |
NO ADVERSE EVENT |
73 |
0.0004 |
| 852 |
INTESTINAL OBSTRUCTION |
15 |
0.0004 |
| 853 |
GASTROOESOPHAGEAL REFLUX DISEASE |
32 |
0.0004 |
| 854 |
APHASIA |
12 |
0.0004 |
| 855 |
NAUSEA |
311 |
0.0004 |
| 856 |
MYELOSUPPRESSION |
14 |
0.0004 |
| 857 |
CARDIAC FAILURE CONGESTIVE |
31 |
0.0004 |
| 858 |
DERMATITIS |
8 |
0.0004 |
| 859 |
WITHDRAWAL SYNDROME |
16 |
0.0004 |
| 860 |
CONFUSIONAL STATE |
61 |
0.0004 |
| 861 |
DYSARTHRIA |
14 |
0.0004 |
| 862 |
BLOOD SODIUM DECREASED |
7 |
0.0004 |
| 863 |
WHEEZING |
22 |
0.0004 |
| 864 |
DEATH |
318 |
0.0004 |
| 865 |
PRODUCT USE ISSUE |
68 |
0.0004 |
| 866 |
HYPERHIDROSIS |
46 |
0.0004 |
| 867 |
RED BLOOD CELL COUNT DECREASED |
10 |
0.0003 |
| 868 |
FEEDING DISORDER |
7 |
0.0003 |
| 869 |
HYPOTHYROIDISM |
11 |
0.0003 |
| 870 |
MUCOSAL INFLAMMATION |
9 |
0.0003 |
| 871 |
PRODUCT PREPARATION ERROR |
7 |
0.0003 |
| 872 |
SYNCOPE |
34 |
0.0003 |
| 873 |
PRODUCT PRESCRIBING ERROR |
8 |
0.0003 |
| 874 |
TREMOR |
55 |
0.0003 |
| 875 |
INTERSTITIAL LUNG DISEASE |
16 |
0.0003 |
| 876 |
TREATMENT NONCOMPLIANCE |
18 |
0.0003 |
| 877 |
ASTHMA |
37 |
0.0003 |
| 878 |
DRUG ABUSE |
27 |
0.0003 |
| 879 |
HEPATIC STEATOSIS |
6 |
0.0003 |
| 880 |
ABSCESS |
5 |
0.0003 |
| 881 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
11 |
0.0003 |
| 882 |
THERAPEUTIC RESPONSE DECREASED |
18 |
0.0003 |
| 883 |
EPISTAXIS |
22 |
0.0003 |
| 884 |
PRODUCTIVE COUGH |
14 |
0.0003 |
| 885 |
URINARY TRACT INFECTION |
50 |
0.0003 |
| 886 |
THERAPY CESSATION |
15 |
0.0003 |
| 887 |
INFECTION |
42 |
0.0003 |
| 888 |
MENTAL IMPAIRMENT |
7 |
0.0003 |
| 889 |
DYSPHAGIA |
27 |
0.0003 |
| 890 |
GASTROINTESTINAL DISORDER |
25 |
0.0003 |
| 891 |
DISORIENTATION |
11 |
0.0003 |
| 892 |
CHOLELITHIASIS |
9 |
0.0003 |
| 893 |
SKIN EXFOLIATION |
23 |
0.0003 |
| 894 |
BLINDNESS |
11 |
0.0003 |
| 895 |
SEDATION |
7 |
0.0003 |
| 896 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
19 |
0.0003 |
| 897 |
CHILLS |
31 |
0.0003 |
| 898 |
MUSCLE TWITCHING |
6 |
0.0003 |
| 899 |
NIGHTMARE |
9 |
0.0003 |
| 900 |
INFUSION RELATED REACTION |
17 |
0.0003 |
| 901 |
SWOLLEN TONGUE |
8 |
0.0003 |
| 902 |
HAEMATOCHEZIA |
14 |
0.0003 |
| 903 |
MENTAL DISORDER |
11 |
0.0003 |
| 904 |
EXTRA DOSE ADMINISTERED |
10 |
0.0002 |
| 905 |
ASTHENIA |
92 |
0.0002 |
| 906 |
AGGRESSION |
12 |
0.0002 |
| 907 |
HALLUCINATION |
18 |
0.0002 |
| 908 |
MUSCULAR WEAKNESS |
27 |
0.0002 |
| 909 |
ERYTHEMA |
48 |
0.0002 |
| 910 |
RESPIRATORY TRACT INFECTION |
6 |
0.0002 |
| 911 |
DRUG ADMINISTRATION ERROR |
7 |
0.0002 |
| 912 |
EMOTIONAL DISORDER |
7 |
0.0002 |
| 913 |
DEHYDRATION |
30 |
0.0002 |
| 914 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
10 |
0.0002 |
| 915 |
RENAL DISORDER |
10 |
0.0002 |
| 916 |
DYSPNOEA EXERTIONAL |
8 |
0.0002 |
| 917 |
WHITE BLOOD CELL COUNT DECREASED |
23 |
0.0002 |
| 918 |
PAIN IN JAW |
6 |
0.0002 |
| 919 |
CEREBROVASCULAR ACCIDENT |
35 |
0.0002 |
| 920 |
RASH |
90 |
0.0002 |
| 921 |
COUGH |
57 |
0.0002 |
| 922 |
PSYCHOTIC DISORDER |
6 |
0.0002 |
| 923 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
35 |
0.0002 |
| 924 |
ACCIDENTAL EXPOSURE TO PRODUCT |
20 |
0.0002 |
| 925 |
UNDERDOSE |
14 |
0.0002 |
| 926 |
INCORRECT DOSE ADMINISTERED |
43 |
0.0002 |
| 927 |
RECTAL HAEMORRHAGE |
8 |
0.0002 |
| 928 |
DISTURBANCE IN ATTENTION |
10 |
0.0002 |
| 929 |
MYOCARDIAL INFARCTION |
32 |
0.0002 |
| 930 |
DRUG WITHDRAWAL SYNDROME |
16 |
0.0002 |
| 931 |
DIARRHOEA |
117 |
0.0002 |
| 932 |
CHEST PAIN |
33 |
0.0002 |
| 933 |
HYPERSENSITIVITY |
33 |
0.0002 |
| 934 |
FLUID RETENTION |
9 |
0.0002 |
| 935 |
CONVULSION |
10 |
0.0002 |
| 936 |
URTICARIA |
27 |
0.0002 |
| 937 |
CYSTITIS |
5 |
0.0002 |
| 938 |
MALIGNANT NEOPLASM PROGRESSION |
16 |
0.0002 |
| 939 |
THERAPEUTIC RESPONSE UNEXPECTED |
7 |
0.0002 |
| 940 |
SUICIDAL IDEATION |
14 |
0.0002 |
| 941 |
SPEECH DISORDER |
8 |
0.0002 |
| 942 |
STOMATITIS |
9 |
0.0001 |
| 943 |
ABDOMINAL PAIN UPPER |
30 |
0.0001 |
| 944 |
MYALGIA |
24 |
0.0001 |
| 945 |
ECZEMA |
7 |
0.0001 |
| 946 |
NEPHROLITHIASIS |
6 |
0.0001 |
| 947 |
DEVICE MALFUNCTION |
9 |
0.0001 |
| 948 |
THERAPY INTERRUPTED |
9 |
0.0001 |
| 949 |
AMNESIA |
8 |
0.0001 |
| 950 |
DECREASED APPETITE |
28 |
0.0001 |
| 951 |
CARDIAC DISORDER |
11 |
0.0001 |
| 952 |
DRUG DOSE OMISSION BY DEVICE |
9 |
0.0001 |
| 953 |
DEPRESSED MOOD |
6 |
0.0001 |
| 954 |
MALAISE |
48 |
0.0001 |
| 955 |
FLUSHING |
11 |
0.0001 |
| 956 |
CHEST DISCOMFORT |
11 |
0.0001 |
| 957 |
PAIN |
63 |
0.0001 |
| 958 |
SURGERY |
6 |
0.0001 |
| 959 |
FALL |
34 |
0.0001 |
| 960 |
DISCOMFORT |
6 |
0.0001 |
| 961 |
DIZZINESS |
49 |
0.0001 |
| 962 |
FATIGUE |
75 |
0.0001 |
| 963 |
NEUROPATHY PERIPHERAL |
9 |
0.0001 |
| 964 |
PALPITATIONS |
11 |
0.0001 |
| 965 |
CONTUSION |
9 |
0.0001 |
| 966 |
PRODUCT DOSE OMISSION ISSUE |
27 |
0.0001 |
| 967 |
BLOOD PRESSURE INCREASED |
14 |
0.0001 |
| 968 |
ANXIETY |
26 |
0.0001 |
| 969 |
HEADACHE |
56 |
0.0001 |
| 970 |
VISUAL IMPAIRMENT |
11 |
0.0001 |
| 971 |
MUSCLE SPASMS |
16 |
0.0001 |
| 972 |
MOBILITY DECREASED |
6 |
0.0001 |
| 973 |
PARAESTHESIA |
13 |
0.0001 |
| 974 |
PRODUCT QUALITY ISSUE |
11 |
0.0001 |
| 975 |
BLOOD GLUCOSE INCREASED |
15 |
0.0001 |
| 976 |
PRURITUS |
30 |
0.0001 |
| 977 |
PERIPHERAL SWELLING |
12 |
0.0001 |
| 978 |
ABDOMINAL DISCOMFORT |
12 |
0.0001 |
| 979 |
DEVICE ISSUE |
6 |
0.0001 |
| 980 |
INSOMNIA |
17 |
0.0001 |
| 981 |
INFLUENZA |
7 |
0.0001 |
| 982 |
DYSPEPSIA |
6 |
0.0001 |
| 983 |
ADVERSE EVENT |
5 |
0.0001 |
| 984 |
ARTHRALGIA |
21 |
0.0001 |
| 985 |
WEIGHT DECREASED |
14 |
0.0001 |
| 986 |
DRUG DEPENDENCE |
8 |
0.0000 |
| 987 |
BACK PAIN |
11 |
0.0000 |
| 988 |
GAIT DISTURBANCE |
9 |
0.0000 |
| 989 |
PAIN IN EXTREMITY |
13 |
0.0000 |
| 990 |
WEIGHT INCREASED |
9 |
0.0000 |
| 991 |
DEPRESSION |
9 |
0.0000 |
| 992 |
HOSPITALISATION |
6 |
0.0000 |
| 993 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
7 |
0.0000 |
| 994 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 995 |
ALOPECIA |
6 |
0.0000 |